The headquarters of AZ and Sanofi signed research agreement for the development of new drugs (MOU) with SMC and AMC, respectively

On July 17, according to the related industry, the headquarters of two multinational pharmaceutical companies signed research agreement for the development of new drugs (MOU) with two domestic higher general hospitals during the first half of this year, respectively.

First, AstraZeneca and Samsung Medical Center proceed with joint clinical trial for the purpose of developing new drug targeting...